FINAL PROGR AM - American Society of Gene & Cell Therapy

More documents

Recommendations

Info

AMERICAN SOCIETY OF GENE THERAPY • Final Program 39 SCIENTIFIC PROGRAM SATURDAY, JUNE 4, 2005 Oral Abstract Session 413 Molecular Conjugates: Therapeutic Applications Room: 120/124 Co-Chairs: Lonnie D. Shea, PhD Theresa M. Reineke, PhD (Abstracts #779 - #786) Oral Abstract Session 414 Muscle and Connective Tissue: Gene Therapy for Muscular Dystrophy Room: 230/231 Co-Chairs: Olivier Danos, PhD Paula Clemens, MD (Abstracts #787 - #794) Oral Abstract Session 415 Cellular Immunotherapy of Cancer Using Genetically Modified Effectors Room: Ferrara Theater Chair: Michael Jensen, MD (Abstracts #795 - #802) Oral Abstract Session 416 Cancer-Apoptosis and Suicide Room: 123/127 Co-Chairs: Sunil Chada, PhD Patricia Yotnda, PhD (Abstracts #803 - #810) Oral Abstract Session 417 Gene Therapy Approaches to Pulmonary Disease Room: 261/262 Co-Chairs: Terence R. Flotte, MD Christine L. Halbert, PhD (Abstracts #811 - #818) MEET-THE-INVESTIGATOR LUNCH SESSIONS – 12:30 PM - 1:30 PM Meet-the-Investigator 420 Room: Washington Avenue A Chair: Harry L. Malech, MD - Ex Vivo Hematopoietic Stem Cell Therapy for Inherited Immune Disease Meet-the-Investigator 421 Room: Washington Avenue B Chair: R. Scott McIvor, PhD - Drug Resistance and Transposons in Gene Therapy Research Meet-the-Investigator 422 Room: Washington Avenue C Chair: Luigi Naldini, MD, PhD - Lentiviral Vectors for Stem Cell Gene Transfer PRESIDENTIAL SYMPOSIUM 430 1:45 pm - 4:15 pm Room: America’s Ballroom Chair: Katherine A. High, MD Speaker: George Q. Daley, MD, PhD Presidential Address: Katherine A. High, MD Speaker: George Q. Daley, MD, PhD - Combining Gene Therapy with Cell Therapy Presentation of Top Three Abstracts #819 – Alessandra Recchia, PhD - Molecular Follow-Up of Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation and Donor Lymphocytes Transduced with a Retroviral Vector Expressing HSV-TK and ∆LNGFR #820 – Aurelie Goyenvalle - Highly Efficient Exon-Skipping and Sustained Correction of Muscular Dystrophy Using an Adeno-Associated Viral Vector #821 – Anja Ehrhardt, PhD - Development of a Site-Specific Integrating Gene-Deleted Adenoviral Vector for Sustained Transgene Expression Levels In Vivo
40 8th Annual Meeting • June 1 - 5, 2005 • St. Louis SCIENTIFIC PROGRAM SATURDAY, JUNE 4, 2005 POSTER SESSION III – 4:00 PM - 7:00 PM Hall 2 RNA Virus Vectors: Safety, Therapeutics (Abstracts #823 through #846; Abstract #822 has been moved to Poster Session I) AAV Vectors: Vector Development (Abstracts #847 through #871) Adenovirus Vectors: Vector Technologies (Abstracts #872 through #893) Inborn Errors of Metabolism: Liver and Pancreatic Diseases (Abstracts #894 through #915) Cardiovascular: Myocardial Gene Therapy (Abstracts #916 through #938; Abstract #921 has been moved to Poster Session II) Neurodegenerative Diseases (Abstracts #939 through #960) Neurologic: Other (Abstracts #961 through #972) Gene Therapy for Infections and Vaccines (Abstracts #973 through #995) Infectious Diseases and Vaccines: RNAi for Gene Therapy of Infections (Abstracts #996 through #1003) Cancer - Targeted Gene Therapy: Targeting of Adenoviral Vectors (Abstracts #1004 through #1029; and Abstract #328) Hematologic - New Advances (Abstracts #1030 through #1049) Gene Regulation: Regulated Systems and Tissue Specific Expression (Abstracts #1050 through #1073) SUNDAY, JUNE 5, 2005 SCIENTIFIC SYMPOSIUM – 8:30 AM - 10:00 AM Scientific Symposium 500 Young Investigators Room: America’s Ballroom Co-Chairs: Joseph C. Glorioso, PhD David Bodine, PhD Speakers: Chiara Bonini, MD - Gene Transfer into Peripheral Blood T Lymphocytes: Clinical Benefits and Safety Profile Introduced by Fabio Candotti, MD Michael Kaplitt, MD, PhD - Development of Human Gene Therapy for Neurodegenerative Disorders Introduced by Ronald G. Crystal, MD SIMULTANEOUS ORAL ABSTRACT SESSIONS – 10:15 AM - 12:15 PM Oral Abstract Session 510 Clinical Gene Therapy Room: 240 Complex Co-Chairs: Arthur Nienhuis, MD Terence R. Flotte, MD (Abstracts #1074 - #1079) Oral Abstract Session 511 AAV Vectors: Disease Applications Room: 260/264 Co-Chairs: Roland W. Herzog, PhD Xiao Xiao, PhD (Abstracts #1080 - #1087) Oral Abstract Session 512 Adenovirus Vectors: Adaptive Immunity and Vaccines Room: 120/124 Co-Chairs: Victor Krasnykh, PhD Robin J. Parks, PhD (Abstracts #1088 - # 1095) Oral Abstract Session 513 Naked DNA Gene Transfer: Chromosomal Integration Room: 263/267 Co-Chairs: R. Scott McIvor, PhD Cary Harding, MD (Abstracts #1096 - #1103) Oral Abstract Session 514 Molecular Conjugates: Vector Engineering Room: 265/266 Co-Chairs: Suzie H. Pun, PhD David V. Schaffer, PhD (Abstracts #1104 - #1111)
Page 1 and 2: AMERICAN SOCIETY OF GENE THERAPY 8t
Page 3 and 4: 2 8th Annual Meeting • June 1 - 5
Page 11 and 12: 10 8th Annual Meeting • June 1 -
Page 39: 38 8th Annual Meeting • June 1 -
Page 91 and 92:
90 8th Annual Meeting • June 1 -
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
156 NOTES 8th Annual Meeting • Ju
show all

FINAL PROGR AM - American Society of Gene & Cell Therapy

Create successful ePaper yourself

Delete template?

Save as template?